Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
The CONDUCT-AF trial : rationale and design of a prospective, randomized, multicentre study comparing conduction system and biventricular pacing in patients undergoing atrioventricular node ablation for heart failure with atrial fibrillation
ID
Ivanovski, Maja
(
Author
),
ID
Žižek, David
(
Author
), et al.
PDF - Presentation file,
Download
(694,52 KB)
MD5: F810F85B106BC031BEAD28949BC3F719
URL - Source URL, Visit
https://onlinelibrary.wiley.com/doi/10.1002/ejhf.70013
Image galllery
Abstract
Aims There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA. Methods This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS. Participants will be randomized 1:1 to CSP or BVP with subsequent AVNA and followed for at least 24 months. The primary endpoint is the change in LVEF after 6 months. Secondary endpoints will include time to the first occurrence of worsening HF or cardiovascular death and its individual components, total number of HF hospitalizations, change in quality of life, N-terminal pro-B-type natriuretic peptide, 6-min walk test distance, and safety outcomes. Conclusion The CONDUCT-AF trial will provide critical insights into the optimal pacing modality for patients with HF and refractory AF undergoing AVNA. Recruitment is expected to conclude in 2025, with the first study results anticipated in 2026.
Language:
English
Keywords:
atrioventricular node ablation
,
atrial fibrillation
,
conduction system pacing
,
biventricular pacing
,
heart failure
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
Str. 1927-1934
Numbering:
Vol. 27, iss. 10
PID:
20.500.12556/RUL-176853
UDC:
616.1
ISSN on article:
1879-0844
DOI:
10.1002/ejhf.70013
COBISS.SI-ID:
249377027
Publication date in RUL:
11.12.2025
Views:
427
Downloads:
200
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
European journal of heart failure
Shortened title:
Eur. j. heart fail.
Publisher:
Elsevier
ISSN:
1879-0844
COBISS.SI-ID:
23170053
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Projects
Funder:
UMC Ljubljana
Project number:
TP 20220047
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back